heart disease
Conditions
Interventions
Group remimazolam:Remazolam+sufentanil group
Group propofol:Propofol+sufentanil
Sponsors
People's Hospital of Ningxia Hui Autonomous Region
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) patients with heart disease requiring TEE; 2) ASA grade I-III; 3) aged 18-60 years old; 4) no abnormal liver and kidney function; 5) no mental illness.
Exclusion criteria
Exclusion criteria: 1) difficult airway (modified Mahalanobis score ?-?); 2) hypertension was not well controlled (SBP=160 mmHg and/or DBP=100 mmHg); 3) allergy to study drug, pregnancy or lactation; 4) patients with severe heart failure, severe heart valve disease and atrioventricular block above degree ?.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean arterial pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation success rate;Adverse events (arrhythmia, hypoxemia, body movement, coughing, nausea and vomiting);Patient and operator satisfaction; | — |
Countries
China
Contacts
Public ContactZhang Li
People's Hospital of Ningxia Hui Autonomous Region
Outcome results
None listed